\-\ Texto\\:\\ \ \(0\)\
\-\ laboratory\\:\ \(3\)\
\-\ \\ \\ \\ \\(22apr2004\\)\\ ft4\\:\\ 2\\.11\\ ng\\/dl\\ \\ \\ \\(0\\.89\\-1\\.80\\ ng\\/dl\\)\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ tsh\\:\\ undetectable\\ \\(0\\.35\\-5\\.50\\ uiu\\/ml\\)\ \(0\)\
\-\ \\ \\ \\ \\(10may2004\\)\\ ft4\\:\\ 1\\.26\\ ng\\/dl\\ \\ \\(0\\.89\\-1\\.80\\ ng\\/dl\\)\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ tsh\\:\\ \\<0\\.08\\ uiu\\/ml\\ \\(0\\.35\\-5\\.50\\ uiu\\/ml\\)\ \(0\)\
\-\ pe\\:\\(11may2004\\)\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ no\\ palpable\\ nodules\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ no\\ thyroid\\ enlargement\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ no\\ tenderness\ \(0\)\
\-\ the\\ treatment\\ is\\ observation\\ and\\ allowing\\ the\\ patient\\ to\\ return\\ to\\ normal\\,\\ along\\ with\\ symptomatic\\ treatment\\.\\ \\ the\\ disease\\ is\\ almost\\ always\\ self\\ limiting\\ with\\ no\\ adverse\\ sequelae\\,\\ but\\ occasionally\\ it\\ recurs\\ and\\ may\\ result\\ in\\ permanent\\ hypothyroidism\\.\ \(0\)\
\-\ dose\\:\\ \\ \\ 4\\.86\\ uci\\ i\\-131\\,\\ po\\.\ \(0\)\
\-\ \\ \\	4\\.65\\ mci\\ tc99m\\-pertechnatate\\,\\ iv\\.\ \(0\)\
\-\ procedure\\:\\ \\ approximately\\ 24\\ hours\\ prior\\ to\\ imaging\\,\\ patient\\ was\\ given\\ iodine\\-131\\ po\\.\\ \\ uptake\\ was\\ calculated\\ with\\ iodine\\-131\\ probe\\ detector\\ at\\ four\\ hours\\ and\\ again\\ at\\ 24\\ hours\\.\\ \\ after\\ 24\\-hour\\ uptake\\ was\\ obtained\\,\\ patient\\ was\\ injected\\ with\\ tc\\-99m\\ pertechnetate\\ and\\ planar\\ images\\ and\\ pinhole\\ collimator\\ images\\ were\\ obtained\\ of\\ the\\ thyroid\\.\ \(0\)\
\-\ i\\-131\\ uptake\\:\\	\\ 4\\ hour\\ \\ \\ 3\\.1\\%\\ \\(2\\-12\\%\\)\ \(0\)\
\-\ \\	\\	24\\ hour\\ \\ \\ 4\\.7\\%\\ \\(12\\-30\\%\\)\ \(1\)\
\-\ 24\\ hour\\ tc\\-99m\\ scan\\(11may2004\\)\\:\\ \\ decreased\\ but\\ otherwise\\ physiologic\\-appearing\\ uptake\\.\\ given\\ the\\ amount\\ of\\ background\\ activity\\ and\\ the\\ subsequent\\ decreased\\ target\\ to\\ background\\ ratio\\,\\ the\\ scan\\ demonstrates\\ decreased\\ uptake\\ in\\ the\\ thyroid\\.\ \(0\)\
\-\ subacute\\ thyroiditis\ \(5\)\
\-\ subacute\\ thyroiditis\ \(5\)\
\-\ thyrotoxicosis\\ factitia\ \(0\)\
\-\ hyperthyroidism\\ caused\\ by\\ iodine\\ ingestion\\ \\(e\\.g\\.\\ amiodarone\\,\\ iodine\\-rich\\ contrast\\ agents\\)\ \(0\)\
\-\ struma\\ ovarii\ \(1\)\
\-\ 43\\ y\\/o\\ female\\ with\\ acute\\ onset\\ of\\ agitation\\,\\ heat\\ intolerance\\ and\\ loose\\ stools\\,\\ approximately\\ two\\ weeks\\ ago\\ \\(prior\\ to\\ the\\ day\\ of\\ thyroid\\ uptake\\/scan\\)\\.\\ upon\\ questioning\\ on\\ day\\ of\\ scan\\,\\ relates\\ having\\ an\\ upper\\ respiratory\\ infection\\ 4\\-5\\ weeks\\ prior\\ to\\ having\\ symptoms\\.\ \(0\)\
\-\ see\\ factoid\\.\ \(59\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ uptake\\:\\ 0\\.24799579111946593\ \(0\)\
\-\ iodine\\:\\ 0\\.23705840982313656\ \(0\)\
\-\ hour\\:\\ 0\\.2038756661469489\ \(0\)\
\-\ 24\\:\\ 0\\.19054520245501771\ \(0\)\
\-\ 11may2004\\:\\ 0\\.17192436631405958\ \(0\)\
\-\ thyroid\\:\\ 0\\.16897261493755705\ \(0\)\
\-\ scan\\:\\ 0\\.12756339272331196\ \(0\)\
\-\ ft4\\:\\ 0\\.1250934448397177\ \(0\)\
\-\ hours\\:\\ 0\\.12290346635048718\ \(0\)\
\-\ background\\:\\ 0\\.12088804817824027\ \(0\)\
\-\ thyroiditis\\:\\ 0\\.11909181830920171\ \(0\)\
\-\ po\\:\\ 0\\.11016280772033811\ \(0\)\
\-\ tsh\\:\\ 0\\.1038724685770709\ \(0\)\
\-\ subacute\\:\\ 0\\.10060696386549521\ \(0\)\
\-\ decreased\\:\\ 0\\.09988647759064924\ \(0\)\
\-\ the\\:\\ 0\\.09653040552187946\ \(0\)\
\-\ having\\:\\ 0\\.09268210186149252\ \(0\)\
\-\ prior\\:\\ 0\\.0902240998385766\ \(0\)\
\-\ 22apr2004\\:\\ 0\\.08596218315702979\ \(0\)\
\-\ 10may2004\\:\\ 0\\.08596218315702979\ \(0\)\
\-\ factitia\\:\\ 0\\.08596218315702979\ \(0\)\
\-\ recurs\\:\\ 0\\.08214145519527337\ \(0\)\
\-\ to\\:\\ 0\\.0806283356862588\ \(0\)\
\-\ detector\\:\\ 0\\.07943060556522495\ \(0\)\
\-\ collimator\\:\\ 0\\.07943060556522495\ \(0\)\
\-\ and\\:\\ 0\\.07775128362978291\ \(0\)\
\-\ undetectable\\:\\ 0\\.07732790723448624\ \(0\)\
\-\ relates\\:\\ 0\\.07732790723448624\ \(0\)\
\-\ obtained\\:\\ 0\\.0760427667019598\ \(0\)\
\-\ was\\:\\ 0\\.07493331741855404\ \(0\)\
\-\ ovarii\\:\\ 0\\.07415730424768018\ \(0\)\
\-\ given\\:\\ 0\\.07395271563793489\ \(0\)\
\-\ probe\\:\\ 0\\.07178914964171211\ \(0\)\
\-\ agitation\\:\\ 0\\.07178914964171211\ \(0\)\
\-\ uci\\:\\ 0\\.0707963296426814\ \(0\)\
\-\ pinhole\\:\\ 0\\.0707963296426814\ \(0\)\
\-\ struma\\:\\ 0\\.0707963296426814\ \(0\)\
\-\ no\\:\\ 0\\.06991899554729923\ \(0\)\
\-\ amiodarone\\:\\ 0\\.06989821470816213\ \(0\)\
\-\ approximately\\:\\ 0\\.06859620547501062\ \(0\)\
\-\ day\\:\\ 0\\.06847902696775986\ \(0\)\
\-\ questioning\\:\\ 0\\.06762572665587534\ \(0\)\
\-\ adverse\\:\\ 0\\.06697560168092498\ \(0\)\
\-\ calculated\\:\\ 0\\.06697560168092498\ \(0\)\
\-\ thyrotoxicosis\\:\\ 0\\.06697560168092498\ \(0\)\
\-\ pertechnetate\\:\\ 0\\.06636745038161528\ \(0\)\
\-\ weeks\\:\\ 0\\.06443003078232412\ \(0\)\
\-\ limiting\\:\\ 0\\.06216205372013785\ \(0\)\
\-\ stools\\:\\ 0\\.06216205372013785\ \(0\)\
\-\ mci\\:\\ 0\\.061436844088150845\ \(0\)\
\-\ allowing\\:\\ 0\\.06109414906407049\ \(0\)\
\-\ permanent\\:\\ 0\\.06076348093964561\ \(0\)\
\-\ planar\\:\\ 0\\.060444024089120134\ \(0\)\
\-\ hyperthyroidism\\:\\ 0\\.060444024089120134\ \(0\)\
\-\ heat\\:\\ 0\\.059545909154600854\ \(0\)\
\-\ intolerance\\:\\ 0\\.05926460245578414\ \(0\)\
\-\ injected\\:\\ 0\\.058725994458102435\ \(0\)\
\-\ ingestion\\:\\ 0\\.05821651499861042\ \(0\)\
\-\ sequelae\\:\\ 0\\.05705169146982203\ \(0\)\
\-\ agents\\:\\ 0\\.056213532673528\ \(0\)\
\-\ hypothyroidism\\:\\ 0\\.05601514482805401\ \(0\)\
\-\ loose\\:\\ 0\\.05601514482805401\ \(0\)\
\-\ target\\:\\ 0\\.055630476128333\ \(0\)\
\-\ self\\:\\ 0\\.05526089642238998\ \(0\)\
\-\ ratio\\:\\ 0\\.053912446497315296\ \(0\)\
\-\ but\\:\\ 0\\.05316153502075391\ \(0\)\
\-\ with\\:\\ 0\\.052627200604479944\ \(0\)\
\-\ of\\:\\ 0\\.05259577464166443\ \(0\)\
\-\ patient\\:\\ 0\\.05244911203269202\ \(0\)\
\-\ occasionally\\:\\ 0\\.05156175820700765\ \(0\)\
\-\ treatment\\:\\ 0\\.05121047512267274\ \(0\)\
\-\ always\\:\\ 0\\.05074184351050922\ \(0\)\
\-\ observation\\:\\ 0\\.050411175386084354\ \(0\)\
\-\ 43\\:\\ 0\\.050303481932747605\ \(0\)\
\-\ dose\\:\\ 0\\.05019700538063304\ \(0\)\
\-\ return\\:\\ 0\\.050091718535558875\ \(0\)\
\-\ images\\:\\ 0\\.04972835501152399\ \(0\)\
\-\ almost\\:\\ 0\\.0482868396759169\ \(0\)\
\-\ again\\:\\ 0\\.04794723266582482\ \(0\)\
\-\ pe\\:\\ 0\\.04443733894493239\ \(0\)\
\-\ four\\:\\ 0\\.043560140943754024\ \(0\)\
\-\ caused\\:\\ 0\\.04310038758699637\ \(0\)\
\-\ amount\\:\\ 0\\.043001196412140334\ \(0\)\
\-\ procedure\\:\\ 0\\.04285434032913537\ \(0\)\
\-\ respiratory\\:\\ 0\\.04275769256291602\ \(0\)\
\-\ nodules\\:\\ 0\\.04270973788129807\ \(0\)\
\-\ upon\\:\\ 0\\.042288786146088636\ \(0\)\
\-\ symptomatic\\:\\ 0\\.041332631853244324\ \(0\)\
\-\ enlargement\\:\\ 0\\.04120945265344639\ \(0\)\
\-\ subsequent\\:\\ 0\\.04069353446831892\ \(0\)\
\-\ at\\:\\ 0\\.04060610987260828\ \(0\)\
\-\ result\\:\\ 0\\.04024114001439593\ \(0\)\
\-\ activity\\:\\ 0\\.03946426716904983\ \(0\)\
\-\ ago\\:\\ 0\\.039329649528161904\ \(0\)\
\-\ laboratory\\:\\ 0\\.03903361236737894\ \(0\)\
\-\ iv\\:\\ 0\\.038407263943777095\ \(0\)\
\-\ otherwise\\:\\ 0\\.03831680173285461\ \(0\)\
\-\ palpable\\:\\ 0\\.03776320077321776\ \(0\)\
\-\ factoid\\:\\ 0\\.037539497101836995\ \(0\)\
\-\ along\\:\\ 0\\.03601221506453774\ \(0\)\
\-\ onset\\:\\ 0\\.03451610156737477\ \(0\)\
\-\ tenderness\\:\\ 0\\.033709562422591086\ \(0\)\
\-\ see\\:\\ 0\\.03343746244126385\ \(0\)\
\-\ infection\\:\\ 0\\.03246970858743613\ \(0\)\
\-\ two\\:\\ 0\\.03192124522202841\ \(0\)\
\-\ is\\:\\ 0\\.02944105468055012\ \(0\)\
\-\ symptoms\\:\\ 0\\.02941040305118082\ \(0\)\
\-\ acute\\:\\ 0\\.029078126481825714\ \(0\)\
\-\ upper\\:\\ 0\\.02872458162971781\ \(0\)\
\-\ imaging\\:\\ 0\\.028248834657873315\ \(0\)\
\-\ were\\:\\ 0\\.027707935892075087\ \(0\)\
\-\ it\\:\\ 0\\.027515228263970612\ \(0\)\
\-\ may\\:\\ 0\\.027050026468436777\ \(0\)\
\-\ demonstrates\\:\\ 0\\.027004744907966623\ \(0\)\
\-\ in\\:\\ 0\\.026743827728332684\ \(0\)\
\-\ contrast\\:\\ 0\\.02611731326677423\ \(0\)\
\-\ after\\:\\ 0\\.02607628980363151\ \(0\)\
\-\ female\\:\\ 0\\.025938130995631286\ \(0\)\
\-\ by\\:\\ 0\\.022826491062954476\ \(0\)\
\-\ disease\\:\\ 0\\.02256345127051844\ \(0\)\
\-\ normal\\:\\ 0\\.021946844991188045\ \(0\)\
\-\ an\\:\\ 0\\.020554831449245817\ \(0\)\
\-\ on\\:\\ 0\\.01623422178254568\ \(0\)\
